173 related articles for article (PubMed ID: 9266985)
21. Mutational analysis of simian immunodeficiency virus from African green monkeys and human immunodeficiency virus type 2.
Shibata R; Adachi A; Sakai H; Ishimoto A; Miura T; Hayami M
J Med Primatol; 1990; 19(3-4):217-25. PubMed ID: 2231682
[TBL] [Abstract][Full Text] [Related]
22. Overlapping cis sites used for splicing of HIV-1 env/nef and rev mRNAs.
Swanson AK; Stoltzfus CM
J Biol Chem; 1998 Dec; 273(51):34551-7. PubMed ID: 9852125
[TBL] [Abstract][Full Text] [Related]
23. Accurate and differential quantitation of HIV-1 tat, rev and nef mRNAs by competitive PCR.
Merzouki A; Mo T; Vellani N; Pattullo A; Estable M; O'Shaughnessy M; Tsoukas C; Cassol S
J Virol Methods; 1994 Dec; 50(1-3):115-28. PubMed ID: 7714034
[TBL] [Abstract][Full Text] [Related]
24. Control of human immunodeficiency virus replication by the tat, rev, nef and protease genes.
Karn J
Curr Opin Immunol; 1991 Aug; 3(4):526-36. PubMed ID: 1755979
[TBL] [Abstract][Full Text] [Related]
25. Rev-induced modulation of Nef protein underlies temporal regulation of human immunodeficiency virus replication.
Ahmad N; Maitra RK; Venkatesan S
Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6111-5. PubMed ID: 2788283
[TBL] [Abstract][Full Text] [Related]
26. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
Li XD; Moore B; Cloyd MW
Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
[TBL] [Abstract][Full Text] [Related]
27. Splicing variability in HIV type 1 revealed by quantitative RNA polymerase chain reaction.
Neumann M; Harrison J; Saltarelli M; Hadziyannis E; Erfle V; Felber BK; Pavlakis GN
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1531-42. PubMed ID: 7888208
[TBL] [Abstract][Full Text] [Related]
28. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines.
Brack-Werner R; Kleinschmidt A; Ludvigsen A; Mellert W; Neumann M; Herrmann R; Khim MC; Burny A; Müller-Lantzsch N; Stavrou D
AIDS; 1992 Mar; 6(3):273-85. PubMed ID: 1373627
[TBL] [Abstract][Full Text] [Related]
29. Ordered appearance of human immunodeficiency virus type 1 nucleic acids following high multiplicity infection of macrophages.
Munis JR; Kornbluth RS; Guatelli JC; Richman DD
J Gen Virol; 1992 Aug; 73 ( Pt 8)():1899-906. PubMed ID: 1645135
[TBL] [Abstract][Full Text] [Related]
30. The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs.
D'Agostino DM; Felber BK; Harrison JE; Pavlakis GN
Mol Cell Biol; 1992 Mar; 12(3):1375-86. PubMed ID: 1545819
[TBL] [Abstract][Full Text] [Related]
31. Infection of baboons with simian/human immunodeficiency viruses.
Allan JS; Ray P; Broussard S; Whitehead E; Hubbard G; Butler T; Brasky K; Luciw P; Cheng-Mayer C; Levy JA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(5):429-41. PubMed ID: 7627620
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
Mautino MR; Keiser N; Morgan RA
J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
[TBL] [Abstract][Full Text] [Related]
33. Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) functions in a position-dependent manner.
Rizvi TA; Schmidt RD; Lew KA
Virology; 1997 Sep; 236(1):118-29. PubMed ID: 9299624
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms for the inhibition of HIV replication by interferons-alpha, -beta, and -gamma in primary human macrophages.
Meylan PR; Guatelli JC; Munis JR; Richman DD; Kornbluth RS
Virology; 1993 Mar; 193(1):138-48. PubMed ID: 7679856
[TBL] [Abstract][Full Text] [Related]
35. Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef.
Fischer M; Joos B; Hirschel B; Bleiber G; Weber R; Günthard HF;
J Infect Dis; 2004 Dec; 190(11):1979-88. PubMed ID: 15529263
[TBL] [Abstract][Full Text] [Related]
36. Identification of small molecule modulators of HIV-1 Tat and Rev protein accumulation.
Balachandran A; Wong R; Stoilov P; Pan S; Blencowe B; Cheung P; Harrigan PR; Cochrane A
Retrovirology; 2017 Jan; 14(1):7. PubMed ID: 28122580
[TBL] [Abstract][Full Text] [Related]
37. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1.
Schwartz S; Felber BK; Benko DM; Fenyö EM; Pavlakis GN
J Virol; 1990 Jun; 64(6):2519-29. PubMed ID: 2335812
[TBL] [Abstract][Full Text] [Related]
38. Functionally-inactive and immunogenic Tat, Rev and Nef DNA vaccines derived from sub-Saharan subtype C human immunodeficiency virus type 1 consensus sequences.
Scriba TJ; zur Megede J; Glashoff RH; Treurnicht FK; Barnett SW; van Rensburg EJ
Vaccine; 2005 Jan; 23(9):1158-69. PubMed ID: 15629359
[TBL] [Abstract][Full Text] [Related]
39. Regulation of expression of human immunodeficiency virus.
Pavlakis GN; Felber BK
New Biol; 1990 Jan; 2(1):20-31. PubMed ID: 2078551
[TBL] [Abstract][Full Text] [Related]
40. Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes.
Klotman ME; Kim S; Buchbinder A; DeRossi A; Baltimore D; Wong-Staal F
Proc Natl Acad Sci U S A; 1991 Jun; 88(11):5011-5. PubMed ID: 1711215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
